Stay updated on CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.

Latest updates to the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.6.3 has been added to the record history, indicating a site-wide interface update that supersedes the prior v3.6.2 revision. This reflects maintenance or UI changes rather than alterations to trial data.SummaryDifference0.1%

- Check8 days agoChange DetectedAn additional revision entry (v3.6.2) is added to the history, indicating an update to the study record. The older revision (v3.6.0) is removed from the history log.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study's recruitment status is updated to 'No longer looking for participants', indicating enrollment closed. The record also includes a new revision v3.6.0 and shows the prior revision v3.5.5 has been removed.SummaryDifference0.5%

- Check29 days agoChange DetectedThe study record history shows a new revision v3.5.5, replacing the previous v3.5.4, indicating an update to the page's revision metadata.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 for the study record history.SummaryDifference0.1%

- Check72 days agoChange DetectedUpdates the ClinicalTrials.gov page revision/version label from v3.5.2 to v3.5.3, indicating a minor site build or UI release rather than a change to the underlying clinical trial record.SummaryDifference0.1%

Stay in the know with updates to CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.